PubMed

Risk management and regulations for lower limb medical exoskeletons: a review.

PMID: 28533700 · 2017-05-09

Y, o, n, g, t, i, a, n, , H, e, ;, , D, a, v, i, d, , E, g, u, r, e, n, ;, , T, r, i, e, u, , P, h, a, t, , L, u, u, ;, , J, o, s, e, , L, , C, o, n, t, r, e, r, a, s, -, V, i, d, a, l

ЖурналMedical devices (Auckland, N.Z.)

Год2017-05-09

PMID28533700

Аннотация

Gait disability is a major health care problem worldwide. Powered exoskeletons have recently emerged as devices that can enable users with gait disabilities to ambulate in an upright posture, and potentially bring other clinical benefits. In 2014, the US Food and Drug Administration approved marketing of the ReWalk™ Personal Exoskeleton as a class II medical device with special controls. Since then, Indego™ and Ekso™ have also received regulatory approval. With similar trends worldwide, this ind

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.